On June 11, 2025, ZyVersa Therapeutics, Inc. held its annual meeting where stockholders approved several proposals, including increasing their equity incentive plan shares by 100,000 to 382,122; 1,637,000 shares issuable from warrants issued in November 2024; and 2,105,265 shares from warrants issued in March 2025.